Determinants of the provision of ethylene oxide medical surveillance in Massachusetts hospitals.
An in-depth survey of ethylene oxide (EtO) health and safety was conducted in Massachusetts hospitals (n = 92) to investigate the determinants of the provision of medical surveillance for EtO exposure. We have evaluated the relationships between provision of EtO medical surveillance and (1) activating OSHA-specified triggers for providing EtO medical surveillance, (2) worker training on EtO health and safety, and (3) various public policy, organizational, group, and individual characteristics. Among the Occupational Safety and Health Administration's (OSHA) five specified triggers for provision of EtO medical surveillance, only accidental worker exposures were related to provision of surveillance (RR = 2.56, P < 0.001). Exceeding the Action Level for 30 or more days, one of OSHA's EtO triggers that is also used in a number of other standards, was not related to provision of surveillance (RR = 0.84, P = 0.714). Reports of coverage of EtO medical surveillance issues in worker training were also correlated with the provision of EtO medical surveillance (RR = 3.68, P < 0.001), supporting OSHA's premise that worker training plays an important role in medical surveillance implementation. The presence of detailed written EtO medical surveillance policies was positively related to the provision of EtO medical surveillance (RR = 1.81, P < 0.001). The relationships between these potential determinants and provision of medical surveillance were also validated in multivariate analyses. Implications for improvement of OSHA medical surveillance implementation through revised trigger schemes, improved worker training efforts, and other measures are discussed. Findings are relevant to the future development of medical surveillance and exposure monitoring policies and practices in both substance-specific and generic contexts.
LaMontagne
A D
AD
Occupational Health Program, Harvard School of Public Health, Boston, Massachusetts 02115-9957, USA.
Rudd
R E
RE
Mangione
T W
TW
Kelsey
K T
KT
D000328:Adult; D004784:Environmental Monitoring; D005027:Ethylene Oxide / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D007318:Inservice Training; D008297:Male; D008404:Massachusetts; D008452:Maximum Allowable Concentration; D008875:Middle Aged; D009784:Occupational Diseases / Q000139:chemically induced / Q000517:prevention & control*; D016273:Occupational Exposure / Q000009:adverse effects / Q000517:prevention & control*; D010564:Personnel, Hospital; D017751:Safety Management; D013242:Sterilization; D014481:United States; D014489:United States Occupational Safety and Health Administration
D005027:Ethylene Oxide